COVID-19 Pandemic in Brazil: Clinical Manifestation and Effect of Comorbidities on Outcomes of Hospitalized SARI Cases
Karl E. Peace
Part of the Medicine and Health Sciences Commons
Works by Karl E. Peace in Medicine and Health Sciences
2023
COVID-19 Pandemic in Brazil: Clinical Manifestation and Effect of Comorbidities on Outcomes of Hospitalized SARI Cases
Karl E. Peace
COVID-19 Pandemic in Brazil: Clinical manifestation and effect of comorbidities on outcomes of hospitalized SARI cases
Karl E. Peace
2022
COVID-19 Pandemic in Brazil: Clinical manifestation and effect of comorbidities on outcomes of hospitalized SARI cases
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Presentations
2021
Informatics and the Covid-19 Crisis: the Role of Information Systems and Clinical Trials Databases
Karl E. Peace
Statistical Considerations for Clinical Trials During COVID-19: Unplanned Changes in Estimands with Two-Stage Adaptive Designs
Karl E. Peace
Peace named Statesboro Herald Humanitarian of the Year: Deen Day Smith recipient 'a true public health hero'
Karl E. Peace
Ron Brookmeyer 2016 Recipient of ASA Karl E. Peace Award for contributions toward betterment of Society
Karl E. Peace
James Cochran 2015 Recipient of ASA Karl E. Peace Award for contributions toward betterment of Society
Karl E. Peace
Richard Simon 2013 Recipient of ASA Karl E. Peace Award for contributions toward betterment of Society
Karl E. Peace
Marvin Zelen First Recipient of ASA Karl E. Peace Award for contributions toward betterment of Society
Karl E. Peace
Mitchell Gail 2017 Recipient of ASA Karl E. Peace Award for contributions toward betterment of Society
Karl E. Peace
Gary Koch 2014 Recipient of ASA Karl E. Peace Award for contributions toward betterment of Society
Karl E. Peace
Master of Adversity: Overcoming long odds, Karl E. Peace was pivotal in JPHCOPH founding
Karl E. Peace
Assessing the Validity of Statistical Inferences in Public Health Research: An Evidence-Based, ‘Best-Practices’ Approach
Karl E. Peace
Informatics and the Covid-19 Crisis: the Role of Information Systems and Clinical Trials Databases
Gulzar H. Shah Dr.
2020
Approximating the Baseline Hazard Function by Taylor Series for Interval-Censored Time-to-Event Data
Lili Yu
Spline Nonparametric Quasi-Likelihood Regression Within the Frame of the Accelerated Failure Time Model
Lili Yu
Statistical Considerations for Clinical Trials During COVID-19: Blinded Data Review for Adaptive Estimands
Karl E. Peace
Statistical Considerations for Clinical Trials During COVID-19: Blinded Data Review for Adaptive Estimands (Part III)
Karl E. Peace
Statistical Considerations for Clinical Trials During COVID-19: Blinded Data Review for Adaptive Estimands (Part I)
Karl E. Peace
Approximating the Baseline Hazard Function by Taylor Series for Interval-Censored Time-to-Event Data
Karl E. Peace
Assessing the Validity of Statistical Inferences in Public Health Research: An Evidence-Based, "Best Practices" Approach
Karl E. Peace
Statistical Considerations for Clinical Trials During COVID-19: An Adaptive Hybrid Design for Clinical Development in Rare Diseases
Karl E. Peace
Statistical Analysis Methods for Providing Inferences between Primary Response Measures and Exposure to Study Medication
Karl E. Peace
Statistical Considerations for Clinical Trials During COVID-19: A Two-Stage Adaptive Design for Clinical Trials in Patients with COVID-19 High Risks
Karl E. Peace
Statistical Considerations for Clinical Trials During COVID-19: Accurate COVID-19 Testing in Clinical Trials
Karl E. Peace
Statistical Considerations for Clinical Trials During COVID-19: Blinded Data Review for Adaptive Estimands (Part II)
Karl E. Peace
Statistical Considerations for Clinical Trials During COVID-19: A Two-Stage Adaptive Design for Clinical Trials with Chronic Conditions
Karl E. Peace
Statistical Considerations for Clinical Trials During COVID-19: Confirmatory Adaptive Platform Trial (CAPT) Design for COVID-19 Treatment
Karl E. Peace
Statistical Considerations for Clinical Trials During COVID-19: Confirmatory Adaptive Platform Trial (CAPT) Design for COVID-19 Treatment (Part II)
Karl E. Peace
Statistical Considerations for Clinical Trials During COVID-19: Confirmatory Adaptive Platform Trial (CAPT) Design for COVID-19 Treatment (Part III)
Karl E. Peace
Statistical Considerations for Clinical Trials During COVID-19: Impacts on Minimization Randomization and Mitigations
Karl E. Peace
Statistical Considerations for Clinical Trials During COVID-19: Confirmatory Adaptive Platform Trial (CAPT) Design for COVID-19 Treatment (Part I)
Karl E. Peace
Statistical Considerations for Clinical Trials During COVID-19: Impacts on Permuted Block Randomization and Mitigations
Karl E. Peace
Statistical Considerations for Clinical Trials During COVID-19: Independent DMC for Blinded Data Monitoring and Analysis
Karl E. Peace
Statistical Considerations for Clinical Trials During COVID-19: Integrated Analysis of Efficacy (IAE) with Adaptive Estimands
Karl E. Peace
Statistical Considerations for Clinical Trials During COVID-19: Interim Analysis with Adaptive Estimands Based
Karl E. Peace
Statistical Considerations for Clinical Trials During COVID-19: Natural History Controls for Survival Analysis
Karl E. Peace
Statistical Considerations for Clinical Trials During COVID-19: Natural History Controls for Survival Analysis (Part I)
Karl E. Peace
Statistical Considerations for Clinical Trials During COVID-19: Natural History Controls for Survival Analysis (Part III)
Karl E. Peace
Statistical Considerations for Clinical Trials During COVID-19: Natural History Controls for Survival Analysis (Part II)
Karl E. Peace
Biostatistical Aspects of the Development of Drugs to Prevent NSAID Induced Gastric Ulcers
Karl E. Peace
Clinically Optimal Dosing in the Treatment of Duodenal Ulcers: A Case Study of a Phase III SNDA Clinical Program
Karl E. Peace
Joint Modeling of the Treatment Effect in Clinical Trials with Time-to-Event Endpoint and Safety Covariates
Karl E. Peace
MentalSquares − A Generic Bipolar Support Vector Machine for Mental Disorder Classification, Diagnostic Analysis, and Neurobiological Data Mining
Karl E. Peace
Spline Nonparametric Quasi-Likelihood Regression Within the Frame of the Accelerated Failure Time Model
Karl E. Peace
The Design and Analysis of Pivotal Proof of Efficacy Trials in the Development of Drugs to Treat Panic Disorder
Karl E. Peace
Toward a New Standard for Classification and Analysis of Bipolar Disorders with Mixed States
Karl E. Peace
Yin Yang Mental Squares - An Equilibrium-Based System for Bipolar Neurobiological Pattern Classification and Analysis
Karl E. Peace
YinYang Dynamic Neurobioological Modeling and Diagnostic Analysis of Major Depressive and Bipolar Disorders
Karl E. Peace
Efficacy of Delayed-Release Dimethyl Fumarate vs Glatiramer Acetate on a Novel Composite Outcome Measure of Inflammatory Disease Activity: Post-Hoc Analysis of the CONFIRM Study
Karl E. Peace
Rates of Chlamydia, Gonorhea and Genital Herpes before and after Spring Break and Homecoming at an American Southeastern University
Karl E. Peace
Statistical Considerations for Clinical Trials During COVID-19: Unplanned Changes in Estimands with Two-Stage Adaptive Designs
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications
2019
2018
Efficacy of Delayed-Release Dimethyl Fumarate vs Glatiramer Acetate on a Novel Composite Outcome Measure of Inflammatory Disease Activity: Post-Hoc Analysis of the CONFIRM Study
Karl E. Peace
Adaptive Selection of Counties to Control Versus Intervention Groups in SW Georgia Behavioral Study
Karl E. Peace
Choosing the Function of Baseline Run-In Data for Use as a Covariate in the Analysis of Treatment Data from Phase III Clinical Trials in Hypertension
Karl E. Peace
Genetic Matching: A Better Algorithm for Adjusting Covariate Imbalance for Statistical Data Analysis and Modeling
Karl E. Peace
Discrete Time-to-Event and Score-Based Methods with Application to Composite Endpoint for Assessing Evidence of Disease Activity-Free
Karl E. Peace
2017
Mitchell Gail 2017 Recipient of ASA Karl E. Peace Award for contributions toward betterment of Society
Department of Biostatistics, Epidemiology and Environmental Health Sciences Faculty Media Appearances and Interviews
2016
Inequalities and Approximations of Weighted Distributions by Lindley Reliability Measures, and the Lindley-Cox Model with Applications
Broderick O. Oluyede
A Comparison of Size and Power of Tests of Hypotheses on Parameters Based on Two Generalized Lindley Distributions
Karl E. Peace
A Comparison of Size and Power of Tests of Hypotheses on Parameters Based on Two Generalized Lindley Distributions
Karl E. Peace
A Comparison of Size and Power of Tests of Hypotheses on Parameters Based on Two Generalized Lindley Distributions
Karl E. Peace
Size and Power of Tests of Hypotheses on Survival Parameters from the Lindley Distribution with Covariates
Karl E. Peace
Size and Power of Tests of Hypotheses on Survival Parameters from the Lindley Distribution with Covariates
Karl E. Peace
Yin Yang Mental Squares - An Equilibrium-Based System for Bipolar Neurobiological Pattern Classification and Analysis
Wen-Ran Zhang
Toward a New Standard for Classification and Analysis of Bipolar Disorders with Mixed States
Wen-Ran Zhang
YinYang Dynamic Neurobioological Modeling and Diagnostic Analysis of Major Depressive and Bipolar Disorders
Wen-Ran Zhang
Ron Brookmeyer 2016 Recipient of ASA Karl E. Peace Award for contributions toward betterment of Society
Department of Biostatistics, Epidemiology and Environmental Health Sciences Faculty Media Appearances and Interviews
2015
MentalSquares − A Generic Bipolar Support Vector Machine for Mental Disorder Classification, Diagnostic Analysis, and Neurobiological Data Mining
Wen-Ran Zhang
Causality Is Logically Definable-Toward an Equilibrium-Based Computing Paradigm of Quantum Agents and Quantum Intelligence (QAQI)
Wen-Ran Zhang
Discrete Time-to-Event and Score-Based Methods with Application to Composite Endpoint for Assessing Evidence of Disease Activity-Free
Biostatistics Faculty Presentations
Size and Power of Tests of Hypotheses on Survival Parameters from the Lindley Distribution with Covariates
Karl E. Peace
Inequalities and Approximations of Weighted Distributions by Lindley Reliability Measures, and the Lindley-Cox Model with Applications
Karl E. Peace
Joint Modeling of Treatment Effect on Time-to-Event Endpoint and Safety Covariates in Control Clinical Trial Data Analysis
Karl E. Peace
A Comparison of Size and Power of Tests of Hypotheses on Parameters Based on Two Generalized Lindley Distributions
Karl E. Peace
Efficacy of Delayed-Release Dimethyl Fumarate vs Glatiramer Acetate on a Novel Composite Outcome Measure of Inflammatory Disease Activity: Post-Hoc Analysis of the CONFIRM Study
Karl E. Peace
Rates of Chlamydia, Gonorrhea, and Genital Herpes Before and After Spring Break and Homecoming at a Southeastern American University
Gulzar H. Shah Dr.
Causality Is Logically Definable-Toward an Equilibrium-Based Computing Paradigm of Quantum Agents and Quantum Intelligence (QAQI)
Karl E. Peace
Rates of Chlamydia, Gonorrhea, and Genital Herpes Before and After Spring Break and Homecoming at a Southeastern American University
Karl E. Peace
Extraordinary Journey
Department of Biostatistics, Epidemiology and Environmental Health Sciences Faculty Media Appearances and Interviews
Fruits and Labors of a Purpose Driven Life
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Presentations
James Cochran 2015 Recipient of ASA Karl E. Peace Award for contributions toward betterment of Society
Department of Biostatistics, Epidemiology and Environmental Health Sciences Faculty Media Appearances and Interviews
Filling Gaps: Karl Peace Meets Needs with his Time, Talent and Treasure
Department of Biostatistics, Epidemiology and Environmental Health Sciences Faculty Media Appearances and Interviews
2014
Rates of Chlamydia, Gonorrhea and Genital Herpes Before and After Spring Break and Homecoming at an American Southeastern University
Karl E. Peace
Rates of Chlamydia, Gonorhea and Genital Herpes before and after Spring Break and Homecoming at an American Southeastern University
Biostatistics Faculty Presentations
Sellers-McCroan Award Presented to Dr. Karl Peace
Department of Biostatistics, Epidemiology and Environmental Health Sciences Faculty Media Appearances and Interviews
Gary Koch 2014 Recipient of ASA Karl E. Peace Award for contributions toward betterment of Society
Department of Biostatistics, Epidemiology and Environmental Health Sciences Faculty Media Appearances and Interviews
Statistics Profession Honors Karl E. Peace
Department of Biostatistics, Epidemiology and Environmental Health Sciences Faculty Media Appearances and Interviews
2013
Richard Simon 2013 Recipient of ASA Karl E. Peace Award for contributions toward betterment of Society
Department of Biostatistics, Epidemiology and Environmental Health Sciences Faculty Media Appearances and Interviews
Philanthropy Advances Georgia Southern’s Development
Department of Biostatistics, Epidemiology and Environmental Health Sciences Faculty Media Appearances and Interviews
2012
Grant from C.A.R.E.S of Claxton, GA to Perform Public Health Research in Evans County, GA
Karl E. Peace
Peace Honored with Regents’ Hall of Fame Award
Department of Biostatistics, Epidemiology and Environmental Health Sciences Faculty Media Appearances and Interviews
Marvin Zelen First Recipient of ASA Karl E. Peace Award for contributions toward betterment of Society
Department of Biostatistics, Epidemiology and Environmental Health Sciences Faculty Media Appearances and Interviews
2011
Clinically Optimal Dosing in the Treatment of Duodenal Ulcers: A Case Study of a Phase III SNDA Clinical Program
Karl E. Peace
Grant from C.A.R.E.S of Claxton, GA to Perform Public Health Research in Evans County, GA
Karl E. Peace
Joint Modeling of Treatment Effect on Time-to-Event Endpoint and Safety Covariates in Control Clinical Trial Data Analysis
Karl E. Peace
Genetic Matching: A Better Algorithm for Adjusting Covariate Imbalance for Statistical Data Analysis and Modeling
Karl E. Peace
Genetic Matching: A Better Algorithm for Adjusting Covariate Imbalance for Statistical Data Analysis and Modeling
Karl E. Peace
Joint Modeling of the Treatment Effect in Clinical Trials with Time-to-Event Endpoint and Safety Covariates
Karl E. Peace
Joint Modeling of Treatment Effect on Time-to-Event Endpoint and Safety Covariates in Control Clinical Trial Data Analysis
Karl E. Peace
Joint Modeling of the Treatment Effect in Clinical Trials with Time-to-Event Endpoint and Safety Covariates
Biostatistics Faculty Publications
Karl E. Peace – a Friend to the Biostatistics Community
Department of Biostatistics, Epidemiology and Environmental Health Sciences Faculty Media Appearances and Interviews
Master of Adversity: Overcoming long odds, Karl E. Peace was pivotal in JPHCOPH founding
Department of Biostatistics, Epidemiology and Environmental Health Sciences Faculty Media Appearances and Interviews
Bulloch County’s (no longer) Secret Advantage
Department of Biostatistics, Epidemiology and Environmental Health Sciences Faculty Media Appearances and Interviews
Karl Peace Honored with Painting
Department of Biostatistics, Epidemiology and Environmental Health Sciences Faculty Media Appearances and Interviews
2010
Interval-Censoring in Biomedical and Biopharmaceutical Clinical Trials
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Presentations
Grant from C.A.R.E.S of Claxton, GA to Perform Public Health Research in Evans County, GA
Karl E. Peace
Improve Membership in the APHA Statistics Section
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications
Contributions of Karl Peace recognized by the U.S. Congress
Department of Biostatistics, Epidemiology and Environmental Health Sciences Faculty Media Appearances and Interviews
Foreword by Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications
Sowing what you Reap
Department of Biostatistics, Epidemiology and Environmental Health Sciences Faculty Media Appearances and Interviews
Letter to the Editor, Re: Make a Plan and Follow it
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications
2009
Grant from C.A.R.E.S of Claxton, GA to Perform Public Health Research in Evans County, GA
Karl E. Peace
2008
ASU Graduate Symposium to feature distinguished cancer scholar
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications
Grant from C.A.R.E.S of Claxton, GA to Perform Public Health Research in Evans County, GA
Karl E. Peace
The Pharmaceutical Industry as a Major Player in Public Health
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications
Approval of Drugs in the USA
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications
Approval of Drugs in the US – Hitting close to Home
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications
2007
Does Public Health Matter?
Department of Biostatistics, Epidemiology and Environmental Health Sciences Faculty Media Appearances and Interviews
Every Person must Decide
Department of Biostatistics, Epidemiology and Environmental Health Sciences Faculty Media Appearances and Interviews
The Man from Alligator Creek
Department of Biostatistics, Epidemiology and Environmental Health Sciences Faculty Media Appearances and Interviews
Toward a New Standard for Classification and Analysis of Bipolar Disorders with Mixed States
Karl E. Peace
Toward a New Standard for Classification and Analysis of Bipolar Disorders with Mixed States
Karl E. Peace
Kings of the road: A driving passion for classic car collectors
Department of Biostatistics, Epidemiology and Environmental Health Sciences Faculty Media Appearances and Interviews
2006
Adaptive Selection of Counties to Control versus Intervention Groups in SW Georgia Behavioral Study
Karl E. Peace
Biostatistical Aspects of the Development of Drugs to Prevent NSAID Induced Gastric Ulcers
Biostatistics Faculty Publications
Public Health Classroom
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications
The Importance of the Question Relative to Statistical Analysis in Medical Research
Biostatistics Faculty Publications
Biostatistical Aspects of the Development of Drugs to Prevent NSAID Induced Gastric Ulcers
Karl E. Peace
2005
On Some Statistical Issues Involving Clinical Trials in Oncology
Biostatistics Faculty Presentations
Some Old Regulatory Issues Revisited: Use of Chebyshev’s Inequality in Decisions Regarding Bioequivalence, One-Sided Rather Than Two-Side P-Values in Placebo Controlled Trials, The Need for Placebo in Combination Trials
Karl E. Peace
2004
Biostatistical Aspects of Clinical Drug Development, the Basic Components of a Protocol, and the Statistical Analysis Section of a Protocol
Karl E. Peace
Biostatistical Aspects of the Development of Anti-Ulcer Drugs, Anti-Anginal Drugs and Drugs for the Treatment of Alzheimer’s Disease
Karl E. Peace
Re (Assessing) the Co-Administration of Steroids and Antibiotics in Metastatic Brain Cancer Patients
Karl E. Peace
2003
2002
2001
1998
1996
1995
The Use of Survival Analysis Techniques to Determine the Effect of Long-Term, Open-Label Tacrine Treatment on Nursing Home Placement and Mortality
Karl E. Peace
1994
1993
Population Pharmacodynamic Model Analysis in the Study of Tacrine in Alzheimer's Disease
Karl E. Peace
Issues in Bioequivalence Studies: A Review of the FDA Guidance on Statistical Procedures
Karl E. Peace
Linear Models Analysis of Primary Efficacy Data in the Study of Tacrine in Alzheimer's Disease
Karl E. Peace
Statistical Methods for a Three-Period Crossover Design in Which High Dose Cannot be Used First
Karl E. Peace
1992
Methodologic Aspects of a Population Pharmacodynamic Model for Cognitive Effects in Alzheimer's patients Treated with Tacrine
Karl E. Peace
Statistical Methods for a Three Period Crossover Design in Which High Dose Can’t Be Used First
Karl E. Peace
Statistical Analysis of a Three-Period Crossover Design in Which High Dose Can't Be Used First
Karl E. Peace
Statistical Methods For a Three Period Crossover Design in Which High Dose Can’t Be Used First
Karl E. Peace
1991
The Impact of Investigator Heterogeneity in Clinical Trials on Detecting Treatment Differences
Karl E. Peace
1990
1989
1988
Cost Benefit Assessment of Misoprostol to Cimetidine in the Treatment of Peptic Ulcer Disease
Karl E. Peace
A Blinded Endoscopic Comparative Study of Misoprostol vs. Sucralfate and Placebo in the Prevention of Aspirin Induced Gastric and Duodenal Ulceration
Karl E. Peace
Comparison of Equal-Weight Oral Dosages of Verapamil Hydrochloride and Diltiazem Hydrochloride in Patients with Mild to Moderate Hypertension
Karl E. Peace
Prevention of Gastric Ulceration upon Reinstituting NSAID Therapy in Osteo-Arthritic Patients
Karl E. Peace
A Double Blind, Placebo Controlled, Dose Ranging Clinical Study Evaluating the Safety and Efficacy of Misoprostol in the Prevention of NSAID Induced Ulcers
Karl E. Peace
1987
Definitive Study Design in Assessing the Effectiveness of Misoprostol in the Treatment and Prevention of NSAID Gastric Ulceration
Karl E. Peace
Use of Response Surface Methods in Determining Dose and Frequency in the Development of Anti-Ulcer Drugs
Karl E. Peace
The Effect of Acute Treatment with Misoprostol (MIS), Cimetidine (CIM) and Placebo on Spontaneous Duodenal Ulcer Relapse
Karl E. Peace
A Single Blind Endoscopic Comparison of Misoprostol, Sucralfate and Placebo in the Prevention of Aspirin Induced Gastric Ulceration
Karl E. Peace
Comparative Incidence of Ulcer Relapse Following Treatment by Misoprostol, Cimetidine and Placebo
Karl E. Peace
Effect of Cimetidine 800 mg h.s. and 300 mg q.i.d. on the Pharmaceutics of Warfarin in Patients Receiving Maintenance Warfarin Therapy
Karl E. Peace
Meta-analysis of DU Relapse using actual Patient Data: A comparison of the Effect of Acute Treatment with Cimetidine, Misoprostol and Placebo
Karl E. Peace
A Double Blind Comparison of Verapamil and Diltiazem in Patients with Mild to Moderate Hypertension
Karl E. Peace
Meta-Analysis of Duodenal Ulcer Relapse Using Actual Patient Data: A Comparison of the Effect of Acute Treatment with Cimetidine, Misoprostol and Placebo
Karl E. Peace
The Effect of Acute Treatment with Misoprostol, Cimetidine and Placebo on Spontaneous Duodenal Ulcer Relapse
Karl E. Peace
A Single Blind Comparison of Misoprostol, Sucralfate and Placebo in the Prevention of Aspirin Induced Gastrointestinal Damage
Karl E. Peace
A Single Blind Comparative Study of Misoprostol to Sucralfate and Placebo in the Prevention of Aspirin Induced Ulceration
Karl E. Peace
Comparison of Ulcer Relapse Following Treatment with Misoprostol, Cimetidine and Placebo
Karl E. Peace
Determining the Optimal Dosage Regimen for H2-receptor Antagonist Therapy – a dose validation approach
Karl E. Peace
1986
Estimating the Degree of Equivalence or Non-Equivalence: An Alternative to Bioequivalency Testing
Karl E. Peace
Discussion of the Statistical and Clinical Guidelines for the Content and Format of an Application
Karl E. Peace
Bioequivalence of a new 800 mg Cimetidine Tablet with Commercially Available 400 mg Tablets
Karl E. Peace
Estimating the Degree of Equivalence or Non-Equivalence – An Alternative to Bioequivalency Testing
Karl E. Peace
1985
Statistical Considerations in the Design, Analysis and Interpretation of Single-Dose, Active Duodenal Ulcer Trials; Cimetidine
Karl E. Peace
A Single Nocturnal Dose of Cimetidine in Active Duodenal Ulcer: Result of a United States Multicenter Trial
Karl E. Peace
Comparison of Cimetidine and Ranitidine on Gastric Acid Secretion in Various Age Groups
Karl E. Peace
Efficacy of a Single Nocturnal Dose of Cimetidine in Active Duodenal Ulcer: Result of a United States Multicenter Trial
Karl E. Peace
1984
1983
Minimally Effective Dose of Guanfacine in the Treatment of Mild to Moderate Hypertension
Karl E. Peace
1981
A Note Concerning Carr's Extension of Fisher's Exact Test to More than Two Samples of Equal Size
Karl E. Peace
An Evaluation of Triprolidine and Pseudoephedrine in the Treatment of Allergic Rhinitis
Karl E. Peace
